STOCKWATCH
·
Misc Health and Biotechnology Services
Quarterly ResultMay 5, 2026, 04:15 PM

DaVita Q1 2026 Revenue $3.416B; Diluted EPS $2.87

AI Summary

DaVita Inc. announced strong financial and operating results for the first quarter ended March 31, 2026. The company reported consolidated revenues of $3.416 billion, operating income of $482 million, and diluted earnings per share from continuing operations of $2.87. DaVita also repurchased 3.0 million shares for $403 million during the quarter and raised its full-year 2026 guidance for adjusted operating income and adjusted diluted net income per share.

Key Highlights

  • Consolidated revenues reached $3.416 billion in Q1 2026.
  • Operating income was $482 million for Q1 2026.
  • Diluted EPS from continuing operations was $2.87.
  • Operating cash flow increased to $321 million.
  • Repurchased 3.0 million shares for $403 million.
  • Raised 2026 adjusted operating income guidance to $2.15B-$2.25B.
  • Raised 2026 adjusted diluted EPS guidance to $14.10-$15.20.
  • U.S. dialysis treatments grew 0.1% YoY (normalized).
DVA
Misc Health and Biotechnology Services
DAVITA INC.

Price Impact